drugset / Trial / NCT00938301
A First In Human Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Single Rising Doses In Healthy Adult Volunteers
Non-randomizedCrossoverDouble-blindTreatment
Summary
The purpose of this first in human (FIH) study is to investigate the safety, tolerability, pharmacokinetics ( how the body handles the drug) and pharmacodynamics (how the drug affects the body) of PF-04455242-01 in healthy adult volunteers.
Timeline
- Start
- 2009-04
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | PF-04455242 | Small molecule | 0.5 mg | — |
| Comparator | PF-04455242 | Small molecule | 56 mg | — |